|
Completed
|
NCT00065741 -
Botanical/Drug Interactions in HIV: Glucuronidation
|
Phase 1 |
|
Completed
|
NCT00056953 -
Peer Mentors for Adolescents in HIV Affected Families
|
Phase 2 |
|
Completed
|
NCT00047931 -
HIV-1 Vaccine Test in Uninfected Adult Volunteers
|
Phase 1 |
|
Completed
|
NCT03995862 -
Evaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region
|
|
|
Completed
|
NCT00006327 -
Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
|
Phase 3 |
|
Completed
|
NCT03086200 -
Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals
|
N/A |
|
Completed
|
NCT00076817 -
Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm
|
Phase 1 |
|
Completed
|
NCT00121121 -
Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers
|
Phase 1 |
|
Completed
|
NCT00009685 -
HIV-1 Vaccine Test in Uninfected Adult Volunteers
|
Phase 1 |
|
Completed
|
NCT00031304 -
Screening Protocol for HIV Vaccine Studies
|
|
|
Completed
|
NCT00055237 -
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
|
Phase 2 |
|
Completed
|
NCT02125773 -
Pre-exposure Prophylaxis Accessibility Research and Evaluation 2
|
N/A |
|
Terminated
|
NCT00789789 -
Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials
|
N/A |
|
Completed
|
NCT01761643 -
CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM
|
Phase 4 |
|
Completed
|
NCT01418235 -
Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
|
Phase 1 |
|
Completed
|
NCT00028119 -
HIV Incidence and Participation Retention in Pune, India
|
|
|
Completed
|
NCT00076232 -
A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes
|
Phase 3 |
|
Completed
|
NCT00004579 -
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
|
Phase 1 |
|
Active, not recruiting
|
NCT00013572 -
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
|
Phase 1 |
|
Withdrawn
|
NCT00000809 -
Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women
|
Phase 1 |